Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
This Artificial Intelligence (AI) Stock Could Soar by 67% in 2025. Here's Why.
Artificial intelligence (AI) isn't a theme that's going to wrap up this year. There are still huge gains to be made in this sector, so investors shouldn't avoid it just because it has had a strong two years. One stock that's been the epitome of AI investing is Nvidia (NASDAQ: NVDA). One key point ab...
The Motley Fool
Jan 18, 2025
3 Unstoppable Stocks to Buy in 2025
You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable.Three Motley Fool contributors believe they've identified healthcare stocks in the latter category. Here's why t...
The Motley Fool
Jan 18, 2025
2 Magnificent Dividend Kings Down 19% and 32% to Buy in 2025
Today's Dividends Kings are a who's-who of the most successful dividend growth stocks of our time. This list consists of about 50 publicly traded companies that have increased their dividend payments annually for a minimum of half a century.Typically, most Dividend Kings hold payout ratios above 50%...
The Motley Fool
Jan 18, 2025
This Is One of the Largest Companies in the World...and the Stock Is an Absolute Bargain
There are 10 companies in the world that currently have a market cap of more than $1 trillion. It would be reasonable to assume that none of these businesses have bargain stocks. These companies are very well known, and their valuations prove that huge swaths of the market already believe in their p...
The Motley Fool
Jan 18, 2025
Prediction: These 2 Stocks Could Soar if the Fed Cuts Rates Further in 2025
The Federal Reserve began the process of cutting benchmark interest rates in September 2024, as expected. That came after a long series of rate hikes it initiated in early 2022 to help cool off surging U.S. inflation. So far, it has cut the federal funds rate at three consecutive Fed meetings. The p...
The Motley Fool
Jan 18, 2025
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) owns shares of more than 40 different companies in its portfolio. To be perfectly honest, there's a solid investment case to be made for all of them. After all, Warren Buffett and his team tend to invest in industry leaders with excellent cash flow and d...
The Motley Fool
Jan 18, 2025
This Artificial Intelligence (AI) Stock Is Already Down 10% in 2025, but Wall Street Analysts Believe That It Could Soar Impressively
Enterprise artificial intelligence (AI) software provider C3.ai (NYSE: AI) is off to a shaky start in 2025. Shares of the company have fallen 10% this year, though there has been no company-specific news of note that could have triggered this pullback.However, this seems like an opportunity for inve...
The Motley Fool
Jan 18, 2025
3 Super-Safe Dividend Stocks to Buy for 2025 and Beyond
Dividend cuts can be devastating to an income-focused investor. You lose a portion of your passive income, and a dividend stock's price tends to fall significantly leading up to and after a payout reduction. Because of that, it's best to avoid that situation at all costs. The best way to do that is ...
The Motley Fool
Jan 18, 2025
2 Top Tech Stocks to Buy Right Now
The stock market had a solid 2024, powered by the technology sector, even as the outsized theme of artificial intelligence (AI) continued to feed investors' appetite for outsized returns. But the bull rally seems far from over.While the stock market could take a breather over the next few months, te...
The Motley Fool
Jan 18, 2025
This Is the Average 401(k) Balance for Ages 45 to 54
Welcome to Lake Wobegon, where all the women are strong, all the men are good-looking, and all the children are above average. -- Garrison KeillorWe'd all like to be above average when it comes to financial things, so it's natural to wonder how other folks are doing. Here's a look at average 401(k) ...
The Motley Fool
Jan 18, 2025
Think Lucid Motors Is Expensive? This Chart Might Change Your Mind.
Lucid Motors (NASDAQ: LCID) stock looks expensive according to several traditional valuation metrics. Its price-to-sales ratio, for example, is 9.6. That's significantly higher than other electric car stocks like Rivian, which has a price-to-sales ratio of just 3.0.But there's one factor that Lucid ...
The Motley Fool
Jan 18, 2025
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
GLP-1 drugs have become all the rage for weight loss, with sales for drugs like Novo Nordisk's Ozempic and Eli Lilly's (NYSE: LLY) Mounjaro skyrocketing over the past year. However, Eli Lilly recently surprised investors when it cut its full-year revenue guidance ahead of an investor conference aft...
The Motley Fool
Jan 18, 2025
Possible Stock Splits in 2025: 2 Artificial Intelligence (AI) Giants Up 677% and 797% Over the Last Decade to Buy Now
Companies will commonly split their stock after a strong run-up in price. While it doesn't change any of the underlying fundamentals of the company, it's a strong signal from management that it believes the stock will continue moving higher. As a result, many investors buy shares immediately followi...
The Motley Fool
Jan 18, 2025
Billionaire Bill Ackman Thinks Donald Trump Could Make These 2 Stocks Big Winners -- and Both Are Already Up Over 6X in the Last 12 Months
Billionaire Bill Ackman isn't as much of an activist investor as he used to be. However, he still doesn't mind trying to influence corporate executives to take steps that would boost their companies' share prices when it would make money for his hedge fund. Ackman recently took activist investing to...
The Motley Fool
Jan 18, 2025
The Best Warren Buffett Stocks to Buy With $350 Right Now
With as impressive of an investing track record as Warren Buffett has achieved, you'd expect his Berkshire Hathaway portfolio would be loaded with great stocks. And you'd be right.The good news is that you don't need a huge amount of cash to buy many of those stocks. Here are my picks for the best B...
The Motley Fool
Jan 18, 2025
Is XRP (Ripple) More Likely to Hit $4 or Dogecoin $0.60 in 2025?
Crypto prices are up a ton since Donald Trump won the presidential election in early November, and crypto prices by and large have held up pretty well in the face of a recent rise in Treasury yields. Most investors are still bullish on the regulatory tailwinds Trump could unleash when he takes offic...
The Motley Fool
Jan 18, 2025
7 Facts About Social Security All Americans Should Know
Do you know what the average American's Social Security benefit is? Or why the program is facing financial trouble? In this short video, I discuss seven important Social Security facts that you should know.*Stock prices used were the morning prices of Jan. 15, 2025. The video was published on Jan. 1...
The Motley Fool
Jan 18, 2025
Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks
Dividend yields can be like ladders: The higher you go, the scarier it gets. Many of us are more afraid of falling off an especially tall ladder than a shorter one. Many investors are more leery of ultra-high dividend yields because they're afraid the dividends could be in jeopardy.However, some sto...
The Motley Fool
Jan 18, 2025
3 No-Brainer Fintech Stocks to Buy With $200 Right Now
Many fintech stocks soared in 2020 and 2021 as pandemic-driven digital transactions, stimulus checks, and low interest rates generated strong tailwinds for the sector. But in 2022 and 2023, a lot of those stocks tumbled as inflation, rising rates, and other macroeconomic headwinds curbed consumer sp...
The Motley Fool
Jan 18, 2025
Is Novo Nordisk Stock a Buy?
It hasn't been a great period for investors in Novo Nordisk (NYSE: NVO) despite its ongoing status as one of the pharmaceutical industry's apex competitors in the field of cardiometabolic drugs. Its shares are down by more than 20% in the last 12 months, and, given a few new competitive developments...
The Motley Fool
Jan 18, 2025
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free